Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: Recent U.S. military experience

Clinical Infectious Diseases

Volumn 27, Issue 6, 1998, Pages 1457-1464

  Aronson, Naomi E ^f   Wortmann, Glenn W ^g   Johnson, Steven C ^a   Jackson, Joan E ^g   Gasser Jr , Robert A ^g   Magill, Alan J ^b   Endy, Timothy P ^c   Coyne, Philip E ^d   Grogl, Max ^g   Benson, Paul M ^g   Beard, Jeffrey S ^e   Tally, John D ^g   Gambel, Jeffrey M ^g   Kreutzer, Richard D ^g   Oster, Charles N ^g  

^a UNIVERSITY OF COLORADO   (United States)

^b California   (Peru)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e Dermatology and Skin Surgery   (United States)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; STIBOGLUCONATE SODIUM;

ADOLESCENT; ADULT; ARTHRALGIA; ARTICLE; BLOOD TOXICITY; CHILD; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LEISHMANIASIS; MAJOR CLINICAL STUDY; MORBIDITY; MYALGIA; PANCREATITIS; PRIORITY JOURNAL; RASH;

EID: 0032450211     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515027     Document Type: Article

References (36)

1. Neal R. Experimental chemotherapy. In: Peters W, Killikendrick R, eds. The leishmaniases in biology and medicine. Volume II: clinical aspects and control New York: Academic Press, 1987:795-845.
2. Chance M. New developments in the chemotherapy of leishmaniasis. Ann Trop Med Parasitol 1995; 89(suppl 1):37-43.
3. Berman J. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24:684-703.
4. Herwaldt B, Berman J. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46:296-306.
5. Jackson J, Tally J, Tang D. An in vitro method for drug sensitivity testing of Leishmania. Am J Trop Med Hyg 1989; 41:318-30.
6. Schnur L, Jacobson R. Parasitological techniques. In: Peters W, Killikendrick R, eds. The leishmaniases in biology and medicine. Volume II: clinical aspects and control. New York: Academic Press, 1987:499-541.
7. Hendricks L, Wright N. Diagnosis of cutaneous leishmaniasis by in vitro cultivation of saline aspirates in Schneider's Drosophila medium. Am J Trop Med Hyg 1979; 28:962-4.
8. Kreutzer R, Christensen H. Characterization of Leishmania spp. by isoenzyme electrophoresis. Am J Trop Med Hyg 1980; 29:199-208.
9. Kreutzer R, Souraty N, Semko M. Biochemical identities and differences among Leishmania species and subspecies. Am J Trop Med Hyg 1987; 36:22-32.
10. Magill A, Grogl M, Gasser R, Sun W, Oster C. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993; 328:1383-7.
11. Gasser R, Magill A, Oster C, Franke E, Grogl M, Berman J. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 1994; 18:83-90.
12. Bryceson A. Therapy in man. In: Peters W, Killikendrick R, eds. The leishmaniases in biology and medicine. Volume II: clinical aspects and control. New York: Academic Press, 1987:848-907.
13. Rioux J, Lanotte G, Serres E, Pratlong F, Bastien P, Perieres J. Taxonomy of Leishmania. Use of isoenzymes. Suggestions for a new classification. Ann Parasitol Hum Comp 1990; 65:111-25.
14. Wortmann GW, Aronson NE, Byrd JC, Grever MR, Oster CN. Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis. Clin Infect Dis 1998; 27:509-12.
15. Grögl M, Thomason T, Franke E. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg 1992; 47:117-26.
16. Walton B, Person D, Bernstein R. Leishmaniasis in the U.S. military in the canal zone. Am J Trop Med Hyg 1968; 17:19-24.
17. Takafuji E, Hendricks L, Daubek J, McNeil K, Scagliola H, Diggs C. Cutaneous leishmaniasis associated with jungle training. Am J Trop Med Hyg 1980; 29:516-20.
18. Chulay J, Oster C, McGreevy P, Hendricks L, Kreutzer R. American cutaneous leishmaniasis: presentation and problems of patient management. Rev Soc Bras Med Trop 1988; 21(4):165-72.
19. Sanchez J, Diniega B, Small J, et al. Epidemiologic investigation of an outbreak of cutaneous leishmaniasis in a defined geographic focus of transmission. Am J Trop Med Hyg 1992; 47:47-54.
20. Freeman K. American cutaneous leishmaniasis. J R Army Med Corps 1983; 129:167-73.
21. Evans D, Lanham S, Baldwin C, Peters W. The isolation and isoenzyme characterization of Leishmania braziliensis acquired in Belize. Trans R Soc Trop Med Hyg 1984; 78:35-42.
22. Hepburn N, Tidman M, Hunter J. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1994; 88:700-3.
23. Navin T, Arana B, Arana F, Berman J, Chajon J. Placebo controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992; 165:528-34.
24. Hepburn N, Tidman M, Hunter J. Cutaneous leishmaniasis in British troops from Belize. Br J Dermatol 1993; 128:63-8.
25. Martinez S, Gonzalez M, Vernaza M. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate. Clin Infect Dis 1997; 24:165-9.
26. Franke E, Wignall S, Cruz M, et al. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med 1990; 113: 934-40.
27. Franke E, Llanos-Cuentas A, Echevarria J, et al. Efficacy of 28 day and 40 day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis. Am J Trop Med Hyg 1994; 51:77-82.
28. Saenz R, De Rodriguez C, Johnson C, Berman J. Efficacy and toxicity of Pentostam against Panamanian mucosal leishmaniasis. Am J Trop Med Hyg 1991; 44:394-8.
29. Ballou W, Gordon D, Andujar J, et al. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet 1987; 2:13-6.
30. Guderian R, Chico M, Rogers M, Pattishall K, Grogl M, Berman J. Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis. Am J Trop Med Hyg 1991; 45:92-7.
31. Broeckaert-van Orshoven A, Michielsen P, Vandepitte J. Fatal leishmaniasis in renal transplant patient. Lancet 1979; 2:740-1.
32. McBride M, Linney M, Davidson R, Weber J. Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate. Clin Infect Dis 1995; 21:710.
33. Saenz R, Paz H, Berman J. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 1990; 89: 147-55.
34. Herwaldt B, Arana B, Navin T. The natural history of cutaneous leishmaniasis in Guatemala. J Infect Dis 1992; 165:518-27.
35. Marsden P. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg 1986; 80:854-76.
36. Jones T, Johnson W, Barreto A, et al. Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 1987; 156:73-83.